[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Biodefense Market Report 2016

November 2016 | 113 pages | ID: U44D04C8DBAEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Biodefense

Revenue, means the sales value of Biodefense

This report studies sales (consumption) of Biodefense in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Emergent Biosolutions
  • Hytest
  • GSK
  • Sanofi
  • PharmAthene
  • Bavarian Nordic
  • SIGA Technologies
  • Arbutus Biopharma
  • DynPort Vaccine
  • Xoma Corporation
  • Ichor Medical Systems
  • Aeolus Pharmaceuticals
  • Achaogen
  • Elusys Therapeutics
  • Dynavax Technologies
  • Cleveland BioLabs
  • Soligenix
  • Alnylam Pharmaceuticals
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Anthrax
  • Smallpox
  • Botulism
  • Radiation/Nuclear
Split by applications, this report focuses on sales, market share and growth rate of Biodefense in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Biodefense Market Report 2016

1 BIODEFENSE OVERVIEW

1.1 Product Overview and Scope of Biodefense
1.2 Classification of Biodefense
  1.2.1 Anthrax
  1.2.2 Smallpox
  1.2.3 Botulism
  1.2.4 Radiation/Nuclear
1.3 Application of Biodefense
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Biodefense (2011-2021)
  1.4.1 United States Biodefense Sales and Growth Rate (2011-2021)
  1.4.2 United States Biodefense Revenue and Growth Rate (2011-2021)

2 UNITED STATES BIODEFENSE COMPETITION BY MANUFACTURERS

2.1 United States Biodefense Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Biodefense Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Biodefense Average Price by Manufactures (2015 and 2016)
2.4 Biodefense Market Competitive Situation and Trends
  2.4.1 Biodefense Market Concentration Rate
  2.4.2 Biodefense Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES BIODEFENSE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Biodefense Sales and Market Share by Type (2011-2016)
3.2 United States Biodefense Revenue and Market Share by Type (2011-2016)
3.3 United States Biodefense Price by Type (2011-2016)
3.4 United States Biodefense Sales Growth Rate by Type (2011-2016)

4 UNITED STATES BIODEFENSE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Biodefense Sales and Market Share by Application (2011-2016)
4.2 United States Biodefense Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES BIODEFENSE MANUFACTURERS PROFILES/ANALYSIS

5.1 Emergent Biosolutions
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Biodefense Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Emergent Biosolutions Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Hytest
  5.2.2 Biodefense Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Hytest Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GSK
  5.3.2 Biodefense Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GSK Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Sanofi
  5.4.2 Biodefense Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Sanofi Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 PharmAthene
  5.5.2 Biodefense Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 PharmAthene Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Bavarian Nordic
  5.6.2 Biodefense Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Bavarian Nordic Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 SIGA Technologies
  5.7.2 Biodefense Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 SIGA Technologies Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Arbutus Biopharma
  5.8.2 Biodefense Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Arbutus Biopharma Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 DynPort Vaccine
  5.9.2 Biodefense Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 DynPort Vaccine Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Xoma Corporation
  5.10.2 Biodefense Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Xoma Corporation Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Ichor Medical Systems
5.12 Aeolus Pharmaceuticals
5.13 Achaogen
5.14 Elusys Therapeutics
5.15 Dynavax Technologies
5.16 Cleveland BioLabs
5.17 Soligenix
5.18 Alnylam Pharmaceuticals

6 BIODEFENSE MANUFACTURING COST ANALYSIS

6.1 Biodefense Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biodefense

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Biodefense Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Biodefense Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES BIODEFENSE MARKET FORECAST (2016-2021)

10.1 United States Biodefense Sales, Revenue Forecast (2016-2021)
10.2 United States Biodefense Sales Forecast by Type (2016-2021)
10.3 United States Biodefense Sales Forecast by Application (2016-2021)
10.4 Biodefense Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
LIST OF TABLES AND FIGURES

Figure Picture of Biodefense
Table Classification of Biodefense
Figure United States Sales Market Share of Biodefense by Type in 2015
Figure Anthrax Picture
Figure Smallpox Picture
Figure Botulism Picture
Figure Radiation/Nuclear Picture
Table Application of Biodefense
Figure United States Sales Market Share of Biodefense by Application in 2015
Figure United States Biodefense Sales and Growth Rate (2011-2021)
Figure United States Biodefense Revenue and Growth Rate (2011-2021)
Table United States Biodefense Sales of Key Manufacturers (2015 and 2016)
Table United States Biodefense Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biodefense Sales Share by Manufacturers
Figure 2016 Biodefense Sales Share by Manufacturers
Table United States Biodefense Revenue by Manufacturers (2015 and 2016)
Table United States Biodefense Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Biodefense Revenue Share by Manufacturers
Table 2016 United States Biodefense Revenue Share by Manufacturers
Table United States Market Biodefense Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Biodefense Average Price of Key Manufacturers in 2015
Figure Biodefense Market Share of Top 3 Manufacturers
Figure Biodefense Market Share of Top 5 Manufacturers
Table United States Biodefense Sales by Type (2011-2016)
Table United States Biodefense Sales Share by Type (2011-2016)
Figure United States Biodefense Sales Market Share by Type in 2015
Table United States Biodefense Revenue and Market Share by Type (2011-2016)
Table United States Biodefense Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biodefense by Type (2011-2016)
Table United States Biodefense Price by Type (2011-2016)
Figure United States Biodefense Sales Growth Rate by Type (2011-2016)
Table United States Biodefense Sales by Application (2011-2016)
Table United States Biodefense Sales Market Share by Application (2011-2016)
Figure United States Biodefense Sales Market Share by Application in 2015
Table United States Biodefense Sales Growth Rate by Application (2011-2016)
Figure United States Biodefense Sales Growth Rate by Application (2011-2016)
Table Emergent Biosolutions Basic Information List
Table Emergent Biosolutions Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Emergent Biosolutions Biodefense Sales Market Share (2011-2016)
Table Hytest Basic Information List
Table Hytest Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hytest Biodefense Sales Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table GSK Biodefense Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Biodefense Sales Market Share (2011-2016)
Table PharmAthene Basic Information List
Table PharmAthene Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table PharmAthene Biodefense Sales Market Share (2011-2016)
Table Bavarian Nordic Basic Information List
Table Bavarian Nordic Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bavarian Nordic Biodefense Sales Market Share (2011-2016)
Table SIGA Technologies Basic Information List
Table SIGA Technologies Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table SIGA Technologies Biodefense Sales Market Share (2011-2016)
Table Arbutus Biopharma Basic Information List
Table Arbutus Biopharma Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arbutus Biopharma Biodefense Sales Market Share (2011-2016)
Table DynPort Vaccine Basic Information List
Table DynPort Vaccine Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table DynPort Vaccine Biodefense Sales Market Share (2011-2016)
Table Xoma Corporation Basic Information List
Table Xoma Corporation Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Xoma Corporation Biodefense Sales Market Share (2011-2016)
Table Ichor Medical Systems Basic Information List
Table Ichor Medical Systems Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ichor Medical Systems Biodefense Sales Market Share (2011-2016)
Table Aeolus Pharmaceuticals Basic Information List
Table Aeolus Pharmaceuticals Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aeolus Pharmaceuticals Biodefense Sales Market Share (2011-2016)
Table Achaogen Basic Information List
Table Achaogen Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Achaogen Biodefense Sales Market Share (2011-2016)
Table Elusys Therapeutics Basic Information List
Table Elusys Therapeutics Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Elusys Therapeutics Biodefense Sales Market Share (2011-2016)
Table Dynavax Technologies Basic Information List
Table Dynavax Technologies Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dynavax Technologies Biodefense Sales Market Share (2011-2016)
Table Cleveland BioLabs Basic Information List
Table Cleveland BioLabs Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cleveland BioLabs Biodefense Sales Market Share (2011-2016)
Table Soligenix Basic Information List
Table Soligenix Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Soligenix Biodefense Sales Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Biodefense Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alnylam Pharmaceuticals Biodefense Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biodefense
Figure Manufacturing Process Analysis of Biodefense
Figure Biodefense Industrial Chain Analysis
Table Raw Materials Sources of Biodefense Major Manufacturers in 2015
Table Major Buyers of Biodefense
Table Distributors/Traders List
Figure United States Biodefense Production and Growth Rate Forecast (2016-2021)
Figure United States Biodefense Revenue and Growth Rate Forecast (2016-2021)
Table United States Biodefense Production Forecast by Type (2016-2021)
Table United States Biodefense Consumption Forecast by Application (2016-2021)


More Publications